Your browser doesn't support javascript.
loading
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
Brosseron, Frederic; Maass, Anne; Kleineidam, Luca; Ravichandran, Kishore Aravind; Kolbe, Carl-Christian; Wolfsgruber, Steffen; Santarelli, Francesco; Häsler, Lisa M; McManus, Róisín; Ising, Christina; Röske, Sandra; Peters, Oliver; Cosma, Nicoleta-Carmen; Schneider, Luisa-Sophie; Wang, Xiao; Priller, Josef; Spruth, Eike J; Altenstein, Slawek; Schneider, Anja; Fliessbach, Klaus; Wiltfang, Jens; Schott, Björn H; Buerger, Katharina; Janowitz, Daniel; Dichgans, Martin; Perneczky, Robert; Rauchmann, Boris-Stephan; Teipel, Stefan; Kilimann, Ingo; Görß, Doreen; Laske, Christoph; Munk, Matthias H; Düzel, Emrah; Yakupow, Renat; Dobisch, Laura; Metzger, Coraline D; Glanz, Wenzel; Ewers, Michael; Dechent, Peter; Haynes, John Dylan; Scheffler, Klaus; Roy, Nina; Rostamzadeh, Ayda; Spottke, Annika; Ramirez, Alfredo; Mengel, David; Synofzik, Matthis; Jucker, Mathias; Latz, Eicke; Jessen, Frank.
Afiliação
  • Brosseron F; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Maass A; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Kleineidam L; German Center for Neurodegenerative Diseases (DZNE), Leipziger Straße 44, 39120, Magdeburg, Germany.
  • Ravichandran KA; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Kolbe CC; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Wolfsgruber S; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Santarelli F; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Häsler LM; Institute of Innate Immunity, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • McManus R; Bayer AG, Alfred-Nobel-Straße 50, 40789, Monheim am Rhein, Germany.
  • Ising C; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Röske S; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Peters O; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Cosma NC; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Schneider LS; Hertie Institute for Clinical Brain Research, Department Cellular Neurology, University of Tübingen, Otfried-Müller-Strasse 27, 72076, Tübingen, Germany.
  • Wang X; German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Straße 27, 72076, Tübingen, Germany.
  • Priller J; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Spruth EJ; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Altenstein S; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Schneider A; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Fliessbach K; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Strasse 26, 50931, Köln, Germany.
  • Wiltfang J; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Schott BH; German Center for Neurodegenerative Diseases (DZNE), Charitéplatz 1, 10117, Berlin, Germany.
  • Buerger K; Department of Psychiatry and Psychotherapy, Charité, Charitéplatz 1, 10117, Berlin, Germany.
  • Janowitz D; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Dichgans M; German Center for Neurodegenerative Diseases (DZNE), Charitéplatz 1, 10117, Berlin, Germany.
  • Perneczky R; Department of Psychiatry and Psychotherapy, Charité, Charitéplatz 1, 10117, Berlin, Germany.
  • Rauchmann BS; Department of Psychiatry and Psychotherapy, Charité, Charitéplatz 1, 10117, Berlin, Germany.
  • Teipel S; German Center for Neurodegenerative Diseases (DZNE), Charitéplatz 1, 10117, Berlin, Germany.
  • Kilimann I; Department of Psychiatry and Psychotherapy, Charité, Charitéplatz 1, 10117, Berlin, Germany.
  • Görß D; Department of Psychiatry and Psychotherapy, Technical University Munich, 81675, Munich, Germany.
  • Laske C; German Center for Neurodegenerative Diseases (DZNE), Charitéplatz 1, 10117, Berlin, Germany.
  • Munk MH; Department of Psychiatry and Psychotherapy, Charité, Charitéplatz 1, 10117, Berlin, Germany.
  • Düzel E; German Center for Neurodegenerative Diseases (DZNE), Charitéplatz 1, 10117, Berlin, Germany.
  • Yakupow R; Department of Psychiatry and Psychotherapy, Charité, Charitéplatz 1, 10117, Berlin, Germany.
  • Dobisch L; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Metzger CD; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Glanz W; German Center for Neurodegenerative Diseases (DZNE), Venusberg-Campus 1, 53127, Bonn, Germany.
  • Ewers M; Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn Medical Center, Venusberg-Campus 1, 53127, Bonn, Germany.
  • Dechent P; German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, Göttingen, Germany.
  • Haynes JD; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.
  • Scheffler K; Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Roy N; German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, Göttingen, Germany.
  • Rostamzadeh A; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.
  • Spottke A; Leibniz Institute for Neurobiology, Brenneckestr. 6, 39118, Magdeburg, Germany.
  • Ramirez A; German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Strasse 17, 81377, Munich, Germany.
  • Mengel D; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Feodor-Lynen-Strasse 17, 81377, Munich, Germany.
  • Synofzik M; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Feodor-Lynen-Strasse 17, 81377, Munich, Germany.
  • Jucker M; German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Strasse 17, 81377, Munich, Germany.
  • Latz E; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Feodor-Lynen-Strasse 17, 81377, Munich, Germany.
  • Jessen F; German Center for Neurodegenerative Diseases (DZNE), Feodor-Lynen-Strasse 17, 81377, Munich, Germany.
Alzheimers Res Ther ; 15(1): 13, 2023 01 12.
Article em En | MEDLINE | ID: mdl-36631909
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Interleucina-6 / Doença de Alzheimer / Disfunção Cognitiva / Proteína 1 Semelhante à Quitinase-3 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Interleucina-6 / Doença de Alzheimer / Disfunção Cognitiva / Proteína 1 Semelhante à Quitinase-3 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha